GW Pharmaceuticals claims Epidiolex would cost $32,500 each year

GW Pharmaceuticals claims Epidiolex would cost $32,500 each year GW Pharmaceuticals has revealed the expense of Epidiolex, the initial cannabis-based medicine that’s been authorized because of the United States Food and Drug management. Based on the drug manufacturer, Epidiolex would price each patient on average $32,000 each year. British-based GW Pharmaceuticals made the revelation for[…]